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of FNA used in these cases helped to establish the diagnosis 
of IBC in 4 women presenting with a diffusely enlarged and 
tender breast, resulting in the timely initiation of appropriate 
management. The technique needs to be assessed in a larg-
er cohort of women with diffusely enlarged breast to evalu-
ate its diagnostic utility.  Copyright © 2011 S. Karger AG, Basel 
 Introduction 
 Inflammatory breast cancer (IBC) is a rare type of ag-
gressive cancer which presents as a diffusely enlarged, 
tender, and swollen breast without a discrete lump. The 
patient is put on antibiotics due to the mistaken diagnosis 
of mastitis, and the disease continues to progress  [1] .
 In such patients, a rapid and correct diagnosis is of 
paramount importance to urgently initiate appropriate 
neoadjuvant chemotherapy. 
 Fine-needle aspiration (FNA) cytology can be of great 
value in rapid tissue diagnosis. However, a clinical breast 
examination, mammogram, and other imaging modali-
ties are not helpful in guiding the FNA target  [2, 3] . This 
poses a unique challenge for the cytopathologist who has 
to obtain adequate material on blind FNA to ensure that 
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 Abstract 
 Objectives: To highlight the utility of a tangential approach 
in the fine-needle aspiration (FNA) technique for obtaining 
cellular material adequate for a conclusive diagnosis in dif-
fusely enlarged breast without a discrete lump.  Study De-
sign: FNA was performed on 5 women clinically suspected 
to have inflammatory breast cancer (IBC). All had unilateral 
diffusely enlarged breasts with peau d’orange changes of 
the skin. No distinct lump was palpable. The procedure was 
performed using a 10 cm 3 syringe with a tangential ap-
proach of a 23-gauge needle in all 4 quadrants with extra 
passes in the antigravity areas. Rapid on-site evaluation for 
adequacy was done.  Results: All women were of African de-
scent within the age range of 34–57 years. One case had a 
recent history of lactation. FNA smears showed low-to-mod-
erate cellularity. One case was suspicious and 4 were positive 
for ductal carcinoma. Core biopsy confirmed IBC in 3 cases. 
Two cases had a mastectomy; 1 of these cases had preopera-
tive neoadjuvant chemotherapy.  Conclusion: The approach 
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the diagnosis of malignancy is not missed and differenti-
ate it from benign lesions which can mimic IBC. 
 We report our experience with FNA in 5 cases of IBC 
to highlight the critical steps and precautions that should 
be taken to procure material that is sufficient for a con-
clusive diagnosis. This can be beneficial in resource-lim-
ited settings with a high incidence of breast cancer, such 
as Nairobi, where FNA is preferred over core biopsy as a 
first-line diagnostic approach. To the best of our knowl-
edge, only 2 case reports exist documenting the diagnosis 
of IBC by FNA  [4, 5] .
 Materials and Methods 
 Breast aspiration was performed in 5 cases of clinically sus-
pected IBC over a 1-year period (September 2009 to August 2010). 
In case 1, random sampling yielded inadequate material on the 
first attempt. The FNA procedure was repeated by the consulting 
cytopathologist (N.K.) at our hospital. To improve the diagnostic 
yield, a standard protocol was formulated and adopted for subse-
quent cases.
 FNA was performed with a disposable 23-gauge needle and a 
10-ml syringe using a technique that employed a tangential ap-
proach of the needle in all 4 quadrants ( fig. 1 a, b). In addition, 
antigravity areas were targeted and extra passes done compared 
to heavily edematous lower quadrants of the breast. Overall, 6–8 
passes were performed. Smears from each quadrant were labeled 
separately. Rapid onsite evaluation for sample adequacy was done 
using Diff-Quick staining. The remaining smears were wet fixed 
in 95% alcohol and stained using the Papanicolaou technique. 
Skin core biopsies were done in 3 patients. Two had mastectomies.
 Results 
 All cases were women of African descent ranging in 
age from 34 to 57 years. Two patients were above 50 years 
of age.  Table 1 provides clinicopathological details of the 
5 cases. All patients fulfilled at least 3 clinical criteria for 
the suspicion of IBC; these comprised diffuse enlarge-
ment of the breast, erythema or increased warmth of the 
overlying skin, and edematous skin or peau d’orange. All 
cases presented with unilateral breast enlargement of up 
to 3 months. Only 1 patient (case 2) had a recent history 
of lactation. 
 Upon examination, the breast was tender and diffuse-
ly engorged, and the overlying skin was warm although 
redness was difficult to appreciate due to the natural dark 
pigmentation of the skin. The overlying skin was thick-
ened, firm, and associated with marked peau d’orange 
( fig. 2 a). Two cases (1 and 3) also had axillary node en-
largement and subtle left upper limb swelling. The mam-
mogram showed skin thickening but no masses in the 
breast and enlarged axillary nodes on the same side. Two 
women (cases 4 and 5) had nipple retraction and purulent 
discharge from the nipple. Case 4 also had skin ulceration 
in one area measuring 0.8  ! 0.6 cm ( fig. 2 b). 
 Clinical differential diagnoses included acute mastitis, 
fat necrosis, inflammatory carcinoma, and lymphoma. 
 Cytology Findings 
 FNA smears showed low-to-moderate cellularity. The 
epithelial cells were predominantly distributed in tight, 
3-dimensional, small clusters and dissociated singly. 
There was mild-to-moderate pleomorphism. Four cases 
were diagnosed positive for malignancy based on ade-
quate cellularity, pleomorphism, nuclear irregularity, 
and an increased nuclear-to-cytoplasmic ratio. In case 2, 
a definitive diagnosis of malignancy was deferred for his-
tologic confirmation considering the recent history of 
lactation although the suspicion of malignancy was 
raised. Two cases (4 and 5) also showed some neutrophils 
and lymphocytes surrounding malignant cells scattered 
in the dirty proteinaceous background ( fig. 3 a–c). 
a b
 Fig. 1.  a ,  b Line diagrams showing the tangential approach of the needle during FNA. After piercing the skin 
( a ), the direction of the needle is changed to face upwards towards thickened skin with syringe becoming par-
allel to the horizontal plane ( b ). 
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 Histology 
 Subsequent skin core biopsies and mastectomy speci-
men revealed the characteristic tumor emboli plugging 
dermal lymphatics ( fig. 3 d). The histological diagnosis of 
invasive ductal carcinoma was rendered. Three cases (1, 
3, and 5) were negative for estrogen (ER), progestron (PR), 
and Her2 receptors while 2 cases (2 and 4) were positive 
for ER and PR and negative for Her2 receptors ( table 1 ).
 Discussion 
 First described in 1924, IBC shows a geographic and 
ethnic variability in terms of incidence. It represents about 
less than 5% of all breast cancers in the developed world. 
This rate is high, comprising up to 20% of new cases in Tu-
nisian and North African women, Egyptian women, and 
African American women in the United States and West-
ern Europe  [6–9] . No data is available from East Africa. 
Table 1.  Clinical, radiological, cytological, and histological findings
C linical data Radiological
evaluation
Cytological diagnosis Follow-up and histological 
findings
age, side of the 
breast,  and 
lactation history
duration other changes in addition 
to diffuse enlargement
Case 1 34 years,
left breast,
not pregnant or 
lactating
1 month Erythematous, hardened 
skin with peau d’orange. 
Nipple retraction but no 
nipple discharge. Subtle 
left upper limb swelling.
Ultrasound and 
mammogram 
showed skin 
thickening but no 
masses and 2 
enlarged left 
axillary nodes.
Ductal carcinoma, nuclear 
grade 2 with inflammatory 
cells in a dirty background.
Core biopsy: invasive ductal 
carcinoma, grade 2. Negative 
for ER, PR and Her 2 
receptors.
Case 2 37 years,
left breast, 
stopped 
lactation 1 
month before
2 months No milk discharge. 
Erythematous skin with 
peau d’orange. Took 
antibiotics for 1 week.
Mammogram was 
normal.
Suspicious for carcinoma in 
view of the history of lactation 
in the recent past. 
Subsequently returned with
an enlarged left axillary lymph 
node which was positive for 
carcinoma on FNA.
Received neoadjuvant 
chemotherapy 6 cycles after 
core biopsy in an outside 
facility followed by modified 
radical mastectomy at our 
hospital. Histology showed 
invasive ductal carcinoma, 
grade 2 with lymphovascular 
invasion. Positive for ER and 
PR and negative Her2 
receptors. Prechemotherapy 
status not known.
Case 3 57 years,
right breast
3 months Thickened, hardened 
erythematous skin which is 
ulcerated in one area. Peau 
d’orange and associated 
right arm swelling and 
pain. No palpable axillary 
or supraclavicular lymph 
nodes.
Mammogram 
showed skin 
thickening at the 
breast and an 
enlarged right 
axillary node.
Positive for ductal carcinoma, 
nuclear grade 3.
Total mastectomy. Histology 
showed invasive ductal 
carcinoma, grade 3, with 
lymphovascular invasion. 
Negative for ER, PR, and 
Her2 receptors.
Case 4 44 years,
left breast
6 weeks Inverted nipple showing 
purulent discharge from 
multiple ducts. Thickened, 
hardened erythematous 
skin with peau d’orange.
Mammogram was 
not done.
Positive for ductal carcinoma, 
nuclear grade 3 with 
inflammatory cells in the 
background. Nipple discharge 
smears showed acute and 
chronic inflammation.
Core biopsy: ductal 
carcinoma grade 3. Positive 
for ER, PR, and negative 
Her2 receptors.
Case 5 54 years,
left breast
2 months Retracted nipple showing 
purulent discharge.
Mammogram was 
not done.
Positive for ductal carcinoma, 
nuclear grade 3 with acute and 
chronic inflammatory cells.
Nipple discharge smears 
showed acute inflammation.
Core biopsy: invasive ductal 
carcinoma, grade 3 with 
lymphatic involvement. 
Negative for ER, PR, and 
Her2 receptors.
Her 2 = Human epidermal growth factor receptor 2.
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 The etiology and risk factors of IBC are not known. 
The Epstein-Barr virus and human herpes virus 8 are 
suspected culprits in view of the high incidence in North 
Africa. An association with obesity, a younger age at first 
childbirth, and a younger age at diagnosis has been noted 
in studies from North Africa  [9] . Three of our patients are 
younger and premenopausal.
 The earliest symptom is a color change (usually pink) 
in one breast; it becomes darker red and this change 
spreads over the entire breast. This feature is often missed 
in dark-colored skin such as that of our subjects. Patients 
usually do not have fever. The whole breast becomes rap-
idly enlarged over the next few weeks and the patient may 
feel a sensation of heat, tenderness, and heaviness. The 
usual history is of a rapid onset and a short duration of 3 
months or less as was seen in our cases. Secondary chang-
es such as itching, rash, nipple retraction, and nipple dis-
charge can be present  [1, 2, 10] . 
 Clinically acute mastitis, duct ectasia producing sub-
areolar mastitis, tuberculous mastitis, Mondor’s disease 
(phlebitis of thoracoepigastric vein), and fat necrosis can 
mimic IBC but usually the involved area is well demar-
cated. Pyogenic infection usually subsides within 48 h of 
taking antibiotics. A history of trauma may or may not
be elicited. Diagnosis is more challenging if women are 
younger, pregnant, or breastfeeding as was the case in 1 
of our patients. Lactational mastitis is associated with lo-
calized tenderness, fever, and leukocytosis which may 
help to differentiate it from IBC  [1] .
 The malignant lesions to be considered in the differ-
ential diagnoses include lymphoma and leukemic infil-
tration  [1] . Peripheral blood examination can be useful 
for excluding leukemia. Adenocarcinoma metastatic to 
the breast presenting as inflammatory mastitis can mim-
ic IBC  [11] .
 Physical examination in IBC, unlike noninflamma-
tory locally advanced cancer, often fails to reveal an un-
derlying mass  [12] . The patients are usually given antibi-
otics, and meanwhile the symptoms continue to worsen 
and the skin becomes progressively hard and thickened 
with peau d’orange changes; usually at this stage the pa-
tient is referred for FNA. A mammogram and ultrasound 
confirm skin thickening but do not show any mass  [3] . 
Skin thickening involves the whole breast as was seen in 
2 of our patients who had a mammogram. This finding 
helps in the differentiation of IBC from other inflamma-
tory processes and from scirrhous carcinoma, which 
show local or segmental skin thickening  [13] . Two of our 
patients had axillary lymphadenopathy which has been 
reported in 22–56% of IBC cases (mean 28%)  [6] .
 The histological finding of tumor emboli in dermal 
lymph vessels is characteristic of IBC and is responsible 
for clinical symptoms. This finding without clinical 
symptoms is insufficient to be labeled as IBC. This may 
a b
 Fig. 2.  a Clinical photograph of case 1 showing a diffusely enlarged left breast, peau d’orange, and a retracted 
nipple.  b Clinical photograph of case 3 showing a diffusely enlarged right breast, an inverted nipple, ulceration, 
and peau d’orange. 
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be absent due to a sampling problem in the biopsy. Der-
mal infiltration of lymphocytes is a nonspecific finding 
and is not responsible for clinical symptoms of IBC  [14, 
15] .
 FNA is often the first modality for establishing the ini-
tial tissue diagnosis of carcinoma in suspected IBC cases 
because of the low cost, rapidity, and convenience. The 
major problem is obtaining adequate material due to 
thick skin, edematous stroma, and lack of a discrete mass. 
Once the diagnosis of IBC is established in conjunction 
with clinical features, chemotherapy can be initiated 
quickly. FNA can be useful in follow-up after chemother-
apy. FNA can also pinpoint the exact quadrant to be tar-
geted for core biopsy depending upon the cellular mate-
rial obtained from different quadrants in case a biopsy is 
deemed necessary. It can also procure material for mo-
lecular research in IBC. These are compelling reasons to 
explore various approaches of FNA and identify the best 
one to increase the chances of procuring adequate mate-
rial. 
 The tangential approach described in our study in-
creases the chances of aspirating tumor cell emboli in the 
dermal lymphatics. Using this approach, we were able to 
improve the cellularity adequate for a confident diagno-
a b
c d
 Fig. 3.  a FNA smear from case 1 showing few scattered atypical epithelial cells in a dirty background (Diff-Quick 
stain,  ! 20).  b Repeat FNA smear from case 1 showing a small sheet of malignant epithelial cells in a dirty back-
ground (Diff-Quick stain,  ! 40).  c FNA smear from case 3 showing a sheet of malignant epithelial cells in a dirty 
background (Papanicolaou stain,  ! 20).  d Histological section showing tumor tissue fragments in dermal lym-
phatics (arrow) (H&E stain,  ! 20). 
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sis; however, more large-scale studies are necessary to 
confirm the utility of our approach.
 Neoadjuvant chemotherapy is used as the first line of 
treatment. Patients who respond well to chemotherapy 
are considered for definitive surgery. If the response to 
chemotherapy is poor, then radiotherapy is indicated. 
The 5-year median survival rate is approximately 40%; 
this is mainly due to delays in diagnosis, the lack of ex-
pertise in treating IBC, and its resistance to treatment 
with standard chemotherapy regimes  [16] .
 IBC grows quickly and aggressively, and it has lym-
photactic properties, high angiogenicity, and metastatic 
potential. It shows negative receptor status, increased ex-
pression of p53 (75%), and increased HER-2 amplification 
(40–45%)  [17] . Three of our cases were negative for ER, 
PR, and Her2 receptors; 2 cases were positive for ER and 
PR and negative for Her2 receptors. A search for new mo-
lecular markers which may serve as potential targets for 
future therapeutic agents is underway  [17] .
 We conclude that the diagnosis of IBC can be estab-
lished by FNA using a tangential approach of the needle 
in all 4 quadrants with extra passes in antigravity areas. 
This can help in the timely initiation of chemotherapy. A 
learning curve exists to develop aspirator skills.
 
